510(k) K031857
K031857 is an FDA 510(k) premarket notification submitted by Bayer Diagnostics Corp. for the device "ADVIA CHEMISTRY ALPHA-1 ANTITRYPSIN ASSAY". The FDA issued a decision of Substantially Equivalent on September 4, 2003. The device falls under product code DEM (Alpha-1-Antitrypsin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5130. Bayer Diagnostics Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 4, 2003
- Date Received
- June 16, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Alpha-1-Antitrypsin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5130
- Review Panel
- IM
- Submission Type